Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | SSTR4 | P31391 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | SHBG | P04278 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8710279 | 1.00 | TSHR (0.43) | TSHREPHX1SSTR4MEN1ALDH1A1 | |
| SCHEMBL18498 | 0.89 | TSHR (0.37) | TSHRSHBG | |
| SCHEMBL30928250 | 0.89 | TSHR (0.37) | TSHRSHBG | |
| SCHEMBL9815710 | 0.89 | TSHR (0.37) | TSHRSHBG | |
| SCHEMBL19809440 | 0.87 | EPHX1 (0.37) | EPHX1SSTR4MEN1ALDH1A1LMNA | |
| SCHEMBL9815654 | 0.86 | TSHR (0.33) | TSHR | |
| SCHEMBL25941432 | 0.85 | TSHR (0.43) | TSHREPHX1SSTR4MEN1ALDH1A1 | |
| SCHEMBL133604 | 0.84 | EPHX1 (0.33) | EPHX1SSTR4MEN1ALDH1A1LMNA | |
| SCHEMBL29024831 | 0.84 | EPHX1 (0.33) | EPHX1SSTR4MEN1ALDH1A1LMNA | |
| SCHEMBL9016315 | 0.84 | EPHX1 (0.33) | EPHX1SSTR4MEN1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115197049-B | Method for refining and purifying hydrogenated bisphenol A | 中国石油化工股份有限公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-115197049-A | Method for refining and purifying hydrogenated bisphenol A | 中国石油化工股份有限公司 | 2022-10-18 | — | — | CN | disclosed |
| EP-2966060-A1 | ISOTHIOCYANATE PRODUCTION METHOD, COMPOSITION FOR TRANSPORTING AND STORING N-SUBSTITUTED O-SUBSTITUTED THIOCARBAMATE, AND ISOTHIOCYANATE COMPOSITION | Asahi Kasei Chemicals Corporation (JP) | 2016-01-13 | — | — | EP | disclosed |
| CN-101035833-B | Cyclohexene oxide compound with cyclohexyl or long-chain alkyl and application thereof | TOAGOSEI CO LTD | 2010-09-01 | — | — | CN | disclosed |
| US-7612123-B2 | Cyclohexene oxide compound having cyclohexyl group or long-chain alkyl group, and use thereof | TOAGOSEI CO., LTD. (JP) | 2009-11-03 | — | — | US | disclosed |
| EP-1798251-B1 | CYCLOHEXENE OXIDE COMPOUND HAVING CYCLOHEXYL GROUP OR BRANCHED LONG-CHAIN ALKYL GROUP AND USE THEREOF | TOAGOSEI CO LTD (JP) | 2009-02-25 | — | — | EP | disclosed |
| US-20080108725-A1 | Cyclohexene Oxide Compound Having Cyclohexyl Group or Long-Chain Alkyl Group, and Use Thereof | TOAGOSEI CO., LTD. (JP) | 2008-05-08 | — | — | US | disclosed |
| CN-101035833-A | Cyclohexene oxide compound with cyclohexyl or long-chain alkyl and application thereof | TOAGOSEI CO LTD (JP) | 2007-09-12 | — | — | CN | disclosed |
| EP-1798251-A1 | CYCLOHEXENE OXIDE COMPOUND HAVING CYCLOHEXYL GROUP OR LONG-CHAIN ALKYL GROUP AND USE THEREOF | TOAGOSEI CO., LTD. (JP) | 2007-06-20 | — | — | EP | disclosed |
| US-5723450-A | Substituted pyridines, their preparation, and their use as pesticides and fungicides | HOECHST SCHERING AGREVO GMBH (DE) | 1998-03-03 | — | — | US | disclosed |
| US-4187152-A | Extractive distillation for separating ketones and/or alcohols from phenol and/or cresol | ALLIED CHEMICAL CORPORATION (US) | 1980-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080108725-A1 | Cyclohexene Oxide Compound Having Cyclohexyl Group or Long-Chain Alkyl Group, and Use Thereof | RAD51, HEATR1, DCXR | TSHR 3435/4885EPHX1 492/4885SSTR4 1836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.